STOCK TITAN

CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

CBD Life Sciences Inc. (CBDL) has applied for a beer and liquor license to enter the CBD-infused wine market. The company aims to capitalize on the growing CBD beverage market, projected to reach $2.1 billion by 2025 in the US. The global cannabis beverage market, valued at $1.16 billion in 2023, is expected to grow at a 19.2% CAGR from 2024 to 2030. CBDL reported a 1,744% revenue increase since February 2024 and plans to launch a premium CBD wine line using nanotechnology for enhanced bioavailability. The company targets health-conscious consumers and aims to distribute through restaurants, bars, and liquor stores.

CBD Life Sciences Inc. (CBDL) ha presentato una richiesta per una licenza per la produzione di birra e alcolici per entrare nel mercato del vino infuso con CBD. L'azienda mira a sfruttare il crescente mercato delle bevande a base di CBD, che si prevede raggiungerà 2,1 miliardi di dollari entro il 2025 negli Stati Uniti. Il mercato globale delle bevande a base di cannabis, valutato 1,16 miliardi di dollari nel 2023, dovrebbe crescere a un CAGR del 19,2% dal 2024 al 2030. CBDL ha riportato un aumento del fatturato del 1.744% dal febbraio 2024 e prevede di lanciare una linea di vino CBD premium utilizzando la nanotecnologia per migliorarne la biodisponibilità. L'azienda si rivolge ai consumatori attenti alla salute e mira a distribuire attraverso ristoranti, bar e negozi di liquori.

CBD Life Sciences Inc. (CBDL) ha solicitado una licencia para la elaboración de cerveza y bebidas alcohólicas para ingresar al mercado de vinos infusionados con CBD. La empresa busca capitalizar el creciente mercado de bebidas con CBD, que se proyecta alcanzará 2.1 mil millones de dólares para 2025 en EE. UU. El mercado global de bebidas de cannabis, valorado en 1.16 mil millones de dólares en 2023, se espera que crezca a un CAGR del 19.2% entre 2024 y 2030. CBDL reportó un aumento del 1,744% en los ingresos desde febrero de 2024 y planea lanzar una línea de vino CBD premium utilizando nanotecnología para mejorar la biodisponibilidad. La empresa está dirigida a consumidores conscientes de la salud y busca distribuir a través de restaurantes, bares y licorerías.

CBD Life Sciences Inc. (CBDL)는 CBD가 주입된 와인 시장에 진입하기 위해 맥주 및 주류 허가를 신청했습니다. 이 회사는 2025년까지 미국에서 21억 달러에 이를 것으로 예상되는 성장하는 CBD 음료 시장을 활용하려고 합니다. 2023년 11억 6천만 달러로 평가된 전 세계 대마초 음료 시장은 2024년부터 2030년까지 연평균 19.2% 성장할 것으로 예상됩니다. CBDL은 2024년 2월 이후 1,744%의 매출 증가를 보고했으며, 생체 이용률 향상을 위해 나노기술을 사용한 프리미엄 CBD 와인 라인을 출시할 계획입니다. 이 회사는 건강을 중시하는 소비자들을 타겟으로 하며, 레스토랑, 바 및 주류 판매점을 통해 유통할 계획입니다.

CBD Life Sciences Inc. (CBDL) a demandé une licence de bière et d'alcool pour entrer sur le marché du vin infusé au CBD. L'entreprise vise à tirer parti du marché croissant des boissons au CBD, qui devrait atteindre 2,1 milliards de dollars d'ici 2025 aux États-Unis. Le marché mondial des boissons à base de cannabis, évalué à 1,16 milliard de dollars en 2023, devrait connaître une croissance annuelle moyenne de 19,2% de 2024 à 2030. CBDL a enregistré une augmentation de 1 744% de ses revenus depuis février 2024 et prévoit de lancer une ligne de vin CBD haut de gamme utilisant la nanotechnologie pour améliorer la biodisponibilité. L'entreprise cible les consommateurs soucieux de leur santé et prévoit de distribuer ses produits par le biais de restaurants, de bars et de magasins d'alcool.

CBD Life Sciences Inc. (CBDL) hat einen Antrag auf eine Lizenz zur Herstellung von Bier und alkoholischen Getränken gestellt, um in den Markt für CBD-infundierte Weine einzutreten. Das Unternehmen beabsichtigt, von dem wachsenden Markt für CBD-Getränke zu profitieren, der voraussichtlich bis 2025 2,1 Milliarden Dollar erreichen wird in den USA. Der globale Markt für Cannabis-Getränke, der 2023 auf 1,16 Milliarden Dollar geschätzt wird, wird voraussichtlich von 2024 bis 2030 mit einer CAGR von 19,2% wachsen. CBDL berichtete von einem 1.744%igen Umsatzanstieg seit Februar 2024 und plant, eine Premium-CBD-Weinlinie einzuführen, die Nanotechnologie zur Verbesserung der Bioverfügbarkeit nutzt. Das Unternehmen richtet sich an gesundheitsbewusste Verbraucher und plant die Distribution über Restaurants, Bars und Spirituosengeschäfte.

Positive
  • 1,744% revenue increase since February 2024
  • Entering CBD-infused wine market with projected $2.1B market size by 2025
  • Market expected to grow at 19.2% CAGR (2024-2030)
Negative
  • Pending regulatory approval for beer and liquor license
  • No specific timeline provided for product launch
  • Entering highly competitive alcohol market as new player

Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector.

SCOTTSDALE, AZ / ACCESSWIRE / November 13, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a pioneer in the CBD wellness industry, is thrilled to announce its application for a beer and liquor license, paving the way for its entry into the CBD-infused wine market. This groundbreaking initiative is set to diversify the company's offerings and tap into one of the fastest-growing segments in the cannabis and alcohol industries.

Market Opportunity and Revenue Potential
The global cannabis beverage market is flourishing, with a valuation of $1.16 billion in 2023, projected to soar at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2030. In the U.S. alone, the CBD-infused beverage market is expected to exceed $1.4 billion by 2023, demonstrating an enormous demand for innovative, wellness-focused alcohol alternatives.

The broader cannabis beverage market, including CBD products, is estimated to grow from $4.55 billion in 2021 to a staggering $38.64 billion by 2030, with a CAGR of 27.1%. This trajectory highlights the lucrative potential of CBD-infused wine as an attractive investment and revenue driver for CBDL.

CBDL's Strategic Position
This move into the CBD wine market comes on the heels of a remarkable 1,744% revenue increase for CBD Life Sciences Inc. since February 2024. This growth reflects the company's ability to execute its strategic initiatives and meet consumer demand for premium CBD products effectively. With its beer and liquor license application in process, CBDL is poised to disrupt the wellness and alcohol sectors, further enhancing shareholder value.

"Applying for a beer and liquor license is a monumental milestone for our company," stated Lisa Nelson, President and CEO of CBD Life Sciences Inc. "We are seizing an opportunity to enter an untapped space that bridges the relaxation of wine with the health benefits of CBD. This initiative represents a massive growth opportunity for CBDL, with the potential to create entirely new revenue streams."

The Rise of CBD-Infused Beverages
CBD-infused beverages are rapidly becoming a preferred choice for consumers seeking alternative, functional drinks that support relaxation and well-being without the psychoactive effects of THC. According to market research, more than 50% of consumers in the U.S. have expressed interest in trying CBD beverages, including wines, which offer a sophisticated and wellness-oriented drinking experience.

By leveraging its expertise in CBD product formulation, CBDL plans to launch a premium CBD wine line that combines high-quality ingredients with advanced nanotechnology to enhance bioavailability. The product will cater to a growing demographic seeking healthier, holistic lifestyle options.

What This Means for Investors
The introduction of CBD-infused wines represents a bold leap forward for CBDL. Industry analysts estimate that cannabis beverages, including CBD-infused options, could account for up to 20% of the overall cannabis market by 2030. This shift could translate into billions of dollars in revenue, solidifying CBDL's leadership in the wellness and CBD industries.

With a focus on premium product innovation, distribution partnerships, and regulatory compliance, CBDL is positioning itself as a dominant player in this burgeoning market. This initiative also lays the groundwork for future expansion into other CBD alcohol categories, such as spirits, seltzers, and beers, amplifying the company's growth potential.

Consumer and Industry Impact
CBDL's foray into the CBD wine market is expected to resonate strongly with millennials and health-conscious consumers who value authenticity, wellness, and quality in their beverage choices. This new product line will provide consumers with a unique way to enjoy CBD while enhancing their social and relaxation experiences.

Furthermore, CBD-infused alcohol represents a game-changing opportunity to redefine the wine industry by introducing a wellness-centric alternative to traditional alcoholic beverages. CBDL aims to set a new standard of excellence with its commitment to innovation and quality.

Looking Ahead
CBD Life Sciences Inc. will provide updates on beer and liquor clients such as restaurants, bars, liquor stores and product launch timeline as milestones are achieved. Shareholders can look forward to seeing this transformative initiative come to life in the months ahead.

About CBD Life Sciences Inc.
CBD Life Sciences Inc. is a cutting-edge leader in the CBD and wellness industry, offering a diverse range of innovative products designed to enhance consumer health and well-being. From CBD-infused creams to cutting-edge beverages, CBDL continues to push the boundaries of what is possible in the CBD space.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information:
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.



View the original press release on accesswire.com

FAQ

What is the expected market size for CBD-infused beverages by 2025?

The U.S. CBD-infused beverage market is projected to reach $2.1 billion by 2025.

How much revenue growth has CBDL reported recently?

CBDL reported a 1,744% revenue increase since February 2024.

What type of CBD product is CBDL planning to launch?

CBDL is planning to launch a premium CBD-infused wine line using nanotechnology for enhanced bioavailability.

What is the projected CAGR for the cannabis beverage market from 2024 to 2030?

The cannabis beverage market is projected to grow at a CAGR of 19.2% from 2024 to 2030.

CBD LIFE SCIENCES INC

OTC:CBDL

CBDL Rankings

CBDL Latest News

CBDL Stock Data

750.79k
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Scottsdale